HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
Study sponsor: Emergent BioSolutions
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2006-01Actual
Enrollment · participants21Actual
Source updated2024-03-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.